Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
47.03
-0.62 (-1.30%)
At close: Sep 12, 2025, 4:00 PM EDT
47.34
+0.31 (0.66%)
After-hours: Sep 12, 2025, 7:51 PM EDT
Sanofi Revenue
Sanofi had revenue of 10.74B EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 45.74B, up 15.65% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.74B EUR
Revenue Growth
+15.65%
P/S Ratio
2.14
Revenue / Employee
551,871 EUR
Employees
82,878
Market Cap
115.08B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SNY News
- 2 days ago - Press Release: Sanofi's SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration - GlobeNewsWire
- 3 days ago - US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says - Reuters
- 3 days ago - Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - PRNewsWire
- 3 days ago - Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes - GlobeNewsWire
- 3 days ago - Sanofi (SNY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Sanofi market value tanks following weak results on eczema drug trials - Fast Company
- 9 days ago - Why Is Sanofi Stock Falling Thursday? - Benzinga
- 9 days ago - Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Benzinga